Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cantargia AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Cantargia AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cantargia AB, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Cantargia Raises USD3 Million in Venture Financing 11
Cantargia Raises USD0.46 Million in Venture Financing 12
Cantargia Raises US$1 Million In Venture Financing 13
Partnerships 14
Cantargia and Panorama Research Enter into Co-Development Agreement 14
Licensing Agreements 15
Cantargia Enters into Licensing Agreement with BioWa 15
Equity Offering 16
Cantargia Raises USD7.7 Million in Rights Offering of Shares 16
Cantargia Raises USD2.8 Million in Private Placement of Shares upon Exercise of Warrants 17
Cantargia Plans to Raise upto USD12.2 Million 18
Cantargia Raises Funds through Private Placement of Shares upon Exercise of Warrants 19
Cantargia Raises USD4 Million in Private Placement of Shares upon Exercise of Warrants 20
Cantargia to Raise USD0.5 Million in Private Placement of Shares up on Exercise of Warrants 21
Cantargia Raises USD5.13 Million in IPO 22
Cantargia Raises USD0.07 Million in Private Placement of Shares up on Exercise of Warrants 23
Cantargia AB – Key Competitors 24
Cantargia AB – Key Employees 25
Cantargia AB – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 21, 2018: Cantargia publishes 2018 half year report 27
May 15, 2018: Cantargia publishes interim report for first quarter 2018 28
Feb 28, 2018: Cantargia publishes year end report for 2017 29
Nov 08, 2017: Cantargia publishes interim report for third quarter of 2017 30
Aug 23, 2017: Cantargia publishes half year report 31
Mar 15, 2017: Cantargia publishes year-end report for 2016 32
Corporate Communications 33
Sep 25, 2018: Nasdaq Stockholm welcomes Cantargia to the main market 33
Jul 13, 2018: Cantargia approved for listing on Nasdaq Stockholm First North Premier as part of the process towards Nasdaq Stockholm’s main market 34
May 19, 2017: Cantargia strengthens organisation with CFO 35
Product News 36
10/13/2017: Cantargia announces first patient treated and completed a three weeks safety evaluation period with immuno-oncology antibody CAN04 36
07/21/2017: Cantargia Gains Approval to Initiate the CANFOUR Clinical Trial of Immuno-oncology Product Candidate CAN04 37
06/19/2018: Cantargia’s immuno-oncology antibody CAN04 has obtained the INN nidanilimab by WHO 38
05/16/2018: Cantargias immuno-oncology project CAN04 shows promise in additional cancer forms 39
03/15/2018: Cantargia Presents New Data at AACR on Inhibition of Metastasis by Antibodies Against IL1RAP 40
01/05/2017: Cantargia’s research and development to be presented at Biotech Showcase in San Francisco on 9 January 2017 41
Product Approvals 42
May 12, 2017: Cantargia’s Application to Investigate the Antibody Product Candidate CAN04 in the CANFOUR Phase I/IIa Clinical Trial has been Submitted 42
Clinical Trials 43
Apr 16, 2018: Cantargia presents anti-metastatic effect of IL1RAP blocking antibody at AACR 43
Mar 06, 2018: Cantargia: antibody against ILRAP reduce metastases in experimental cancer model 44
Jun 26, 2017: Cantargia: Preclinical studies of IL1RAP and CAN04 in solid tumours presented at EACR-AACR-SIC in Florence 45
May 08, 2017: Cantargia’s product candidate CAN04 shows good safety properties in studies performed under GLP 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47
Cantargia AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cantargia AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cantargia AB, Deals By Therapy Area, 2012 to YTD 2018 9
Cantargia AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cantargia Raises USD3 Million in Venture Financing 11
Cantargia Raises USD0.46 Million in Venture Financing 12
Cantargia Raises US$1 Million In Venture Financing 13
Cantargia and Panorama Research Enter into Co-Development Agreement 14
Cantargia Enters into Licensing Agreement with BioWa 15
Cantargia Raises USD7.7 Million in Rights Offering of Shares 16
Cantargia Raises USD2.8 Million in Private Placement of Shares upon Exercise of Warrants 17
Cantargia Plans to Raise upto USD12.2 Million 18
Cantargia Raises Funds through Private Placement of Shares upon Exercise of Warrants 19
Cantargia Raises USD4 Million in Private Placement of Shares upon Exercise of Warrants 20
Cantargia to Raise USD0.5 Million in Private Placement of Shares up on Exercise of Warrants 21
Cantargia Raises USD5.13 Million in IPO 22
Cantargia Raises USD0.07 Million in Private Placement of Shares up on Exercise of Warrants 23
Cantargia AB, Key Competitors 24
Cantargia AB, Key Employees 25
List of Figures
Cantargia AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Cantargia AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Cantargia AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9